Co-Delivery of Doxorubicin and Anti-PD-L1 Peptide in Lipid/PLGA Nanocomplexes for the Chemo-Immunotherapy of Cancer
Author:
Affiliation:
1. National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu 610064, China
2. College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou 325035, China
Funder
National Natural Science Foundation of China
Natural Science Foundation of Zhejiang Province
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c00611
Reference52 articles.
1. Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
2. Pembrolizumab versus Ipilimumab in Advanced Melanoma
3. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
4. Cancer immunotherapy using checkpoint blockade
5. Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Leveraging the intratumoral microbiota to treat human cancer: are engineered exosomes an effective strategy?;Journal of Translational Medicine;2024-08-05
2. Nano-Delivery of Immunogenic Cell Death Inducers and Immune Checkpoint Blockade Agents: Single-Nanostructure Strategies for Enhancing Immunotherapy;Pharmaceutics;2024-06-12
3. Co-delivery of doxorubicin and STING agonist cGAMP for enhanced antitumor immunity;International Journal of Pharmaceutics;2024-04
4. Multiscale physics-based in silico modelling of nanocarrier-assisted intravascular drug delivery;Frontiers in Drug Delivery;2024-03-04
5. Superior doxorubicin cellular delivery effect established by optically active mesoporous silica nanoparticles;Drug Delivery and Translational Research;2024-02-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3